RE-BVS – Piemonte Repository

Sfoglia per AUTORE
BRETTI S
Collezione ASL Torino 4

Items : 10

Monitoring toxicity of antiblastic therapies used for colon rectal and breast cancer in 4 centers in piedmont in Journal of Oncology Pharmacy Practice

2012
ASL Torino 4

Goffredo F; Nigro A; Foglio F; Aglietta M; Comandone A; Giubellino E; Bretti S; Ciuffreda L; Bertetto O; Romero M;

Radical resection of a giant, invasive and symptomatic malignant Solitary Fibrous Tumour (SFT) of the pleura in Lung Cancer

2009
ASL Torino 4

Filosso PL; Asioli S; Ruffini E; Rovea P; Macri' L; Sapino A; Bretti S; Lyberis P; Oliaro A;

Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase II study. in American journal of clinical oncology / Am J Clin Oncol. 2005 Jun;28(3):223-6. doi: 10.1097/01.coc.0000144852.75613.56.

2005
ASL Torino 4
ASL Alessandria

Bretti S; Muzio A; Dongiovanni D; Zai S; Castagneto B; Numico G; Botta M; Sinaccio G;

Weekly cisplatin plus capecitabine in metastatic breast cancer patients heavily pretreated with both anthracycline and taxanes in Oncology

2005
ASL Torino 4

Donadio M; Ardine M; Berruti A; Beano A; Bottini A; Mistrangelo M; Bonardi S; Castiglione F; Generali D; Polimeni MA; Bretti S; Alabiso O; Bertetto O;

Multimodal management of stages III-IVa malignant thymoma. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2004 Apr;44(1):69-77. doi: 10.1016/j.lungcan.2003.09.022.

2004
ASL Torino 4
AOU Città della Salute di Torino

Bretti S; Berruti A; Loddo C; Sperone P; Casadio C; Tessa M; Ardissone F; Gorzegno G; Sacco M; Manzin E; Borasio P; Sannazzari GL; Maggi G; Dogliotti L;

Gemcitabine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer: a phase II study. in Anticancer research / Anticancer Res. 2002 Sep-Oct;22(5):3039-43.

2002
ASL Torino 4

Bretti S; Manzin E; Loddo C; Berruti A; Bombaci S; Vellani G; Celano A;

Low dose carboplatin (AUC 4.5) combined with vinorelbine in the treatment of advanced non-small cell lung cancer: a single institution phase II study. in Oncology reports / Oncol Rep. 2001 Mar-Apr;8(2):381-5. doi: 10.3892/or.8.2.381.

2001
ASL Torino 4

Bretti S; Manzin E; Celano A; Ritorto G; Loddo C; Berruti A;

Combined regimen of cisplatin, doxorubicin, and ?-2b interferon in the treatment of advanced malignant pleural mesothelioma: A phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP) in Cancer

2001
ASL Torino 4

Parra HS; Tixi L; Latteri F; Bretti S; Alloisio M; Gravina A; Lionetto R; Bruzzi P; Dani C; Rosso R; Cosso M; Balzarini L; Santoro A; Ardizzoni A;

2001
ASL Torino 4

Parra HS; Tixi L; Latteri F; Bretti S; Alloisio M; Gravina A; Lionetto R; Bruzzi P; Dani C; Rosso R; Cosso M; Balzarini L; Santoro A; Ardizzoni A;

Low dose adriamycin and ifosfamide in the treatment of advanced adult soft tissue sarcomas in Anticancer Research

2000
ASL Torino 4

Comandone A; Bretti S; Bertetto O; Oliva C; Bergnolo P; Bumma C;